Prediction of progression following radical prostatectomy: A multivariate analysis of 721 men with long-term follow-up

American Journal of Surgical Pathology

Volumn 20, Issue 3, 1996, Pages 286-292

  Epstein, Jonathan I ^a,b   Partin, Alan W ^a   Sauvageot, Jurgita ^a   Walsh, Patrick C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Capsular penetration; Gleason grade; Margins; Progression; Radical prostatectomy

Indexed keywords

ARTICLE; CANCER GRADING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; TREATMENT OUTCOME;

DISEASE PROGRESSION; FOLLOW-UP STUDIES; FORECASTING; HUMANS; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROSTATECTOMY; PROSTATIC NEOPLASMS; SEMINAL VESICLES;

EID: 0030025610     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199603000-00004     Document Type: Article

References (11)

1. Catalona WJ, Smith DS. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994;152:1837-42.
2. Epstein JI. Evaluation of radical prostatectomy capsular margins of resection: the significance of margins designated as negative, closely approaching, and positive. Am J Surg Pathol 1990;14:626-32.
3. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression following radical retropubic prostatectomy. Cancer 1993;71:3582-93.
4. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathological and clinical findings to predict tumor extent of non-palpable (stage T1c) prostate cancer. JAMA 1994;271:368-74.
5. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with five years follow-up. J Urol 1993;149:1478-81.
6. Ohori M, Goad JR, Wheeler TM, Eastham JA, Thompson TC, Scardino PT. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 1994;152:1843-9.
7. Partin AW, Piantadosi S, Sanda MG, et al. Selection of men at high risk for recurrence for experimental adjuvant therapy following radical prostatectomy. Urology 1995;45:831-8.
8. Paulson DF. Impact of radical prostatectomy in the management of clinically localized disease. J Urol 1994;152:1826-30.
9. Trapasso JG, deKernion JB, Smith RB, Dorey F. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol 1994; 152:1821-5.
10. Walsh PC. Radical retropubic prostatectomy. In: Campbell's Urology, 6th ed Vol 3. Walsh PC, Retik AB, Stamey TA, Vaughan ED Jr, eds. Philadelphia, PA: W.B. Saunders, 1992:2865-86.
11. Zincke H, Oesterling JE, Glute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994;152:1850-7.